The Leslie Dan Faculty of Pharmacy hosted a live recording of the I’m Pharmacy podcast, bringing together pharmacists, physicians, learners and educators for an open discussion about one of Ontario’s most urgent healthcare challenges: how to strengthen collaboration across the primary care system.
Moderated by Mina Tadrous, the conversation examined the rapid evolution of pharmacy practice — including expanded prescribing authority and new clinical responsibilities — alongside the significant pressures facing family medicine. Panelists reflected on how these shifts are unfolding in real time, and what’s needed to ensure they translate into meaningful, patient-centred progress.
Participants included Eric Wong, MD, President-Elect of the Ontario College of Family Physicians; pharmacist and educator Natalie Crown; practicing physician Dr. Carleigh Clarke, MD; community pharmacist George Hanna (PharmD 2T1); and third-year PharmD student Mehreen Shahid. Together, they highlighted opportunities to improve communication, reduce administrative burden, and strengthen interprofessional training.
The full episode, titled “Relieving the Pressure,” is now available on the I’m Pharmacy podcast.
Listen wherever you find podcasts
More News
Image
Doubling of new prescriptions for ADHD medications among adults since start of COVID-19 pandemic, shows research at St. Michael’s
New research shows prescriptions for ADHD medications among adults have doubled since the start of the COVID-19 pandemic. Professor (Status) Tara Gomes and Associate Professor Mina Tadrous explore the trend in a new paper in CMAJ.
Read More
Image
From school project to non-profit: Business Plan Competition alumni reflect on winning idea
2022 Business Plan Competition winners Team TRUSTi leveraged their skills and experience since graduating to advance harm reduction tool.
Read More
Image
Toronto Centre for Real-World Evidence launches at Leslie Dan Faculty of Pharmacy
New university-based centre, led by director Mina Tadrous, set to build capacity in real-world evidence for drugs and health technologies.
Read More